Organisme
    Hereditary Disease Foundation
    Concours Date limite
    (interne)
    Date limite
    (organisme)
    Lettre d'intention En tout temps En tout temps
    L'organisme finançant ce programme n'est pas agréé.

Type de programme
  • Subvention
Objectif(s)
    The focus of the Hereditary Disease Foundation is on Huntington's disease. Support will be for research projects that will contribute to identifying and understanding the basic defect in Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons.

    Anyone accepting funding from the Hereditary Disease Foundation must agree to abide by the following policy: Propagatable materials (including monoclonal antibodies and recombinant DNAs) should be freely available to other investigators following publication. The Foundation's position is that there be no restrictions or proprietary rights in materials produced with our support.

    The deadline for applications is October 15. Applications will be reviewed in January. To obtain an application, please submit a letter of intent no more than one page long after August 1 to following address,

    Hereditary Disease Foundation
    Attn: Carl D. Johnson, PhD
    3960 Broadway, 6th Floor
    New York, NY 10032 USA
    (2012-04)
Personne-ressource au Vice-rectorat à la recherche et à la création
  • Luce Duval
Domaine(s) concerné(s) Adresse(s) Internet : Fiche numéro : 2068
Dernière mise à jour : 11 décembre 2013

Demande de correction   Demande de correction

www.ulaval.ca